The AI Revolution With Erik Gabrielsen

Erik Gabrielsen is a Software Engineer at Dialexa where he creates custom  software platforms using today’s most innovative technology. As a player on the cusp of the evolving tech revolution he has valuable insights into where the industry may go in the future.

Gabrielsen’s career path was set during middle school after developing an interest in robotics through a club that placed second in a world competition. He spoke recently about a love of engineering and his vision of emerging products and trends that consumers can expect to see.

For example, he sees “Artificial Intelligence and Machine Learning playing a role in software solutions, and the continuous development of Quantum Computers by industry leaders IBM, Google and Microsoft.” He also emphasized a paradigm shift in terms of “the mobile first approach when it comes to building software solutions” based on the increased power of smart devices. Gabrielsen also mentioned Bitcoin and Blockchain as good examples of emerging trends in the tech industry.

Meanwhile, his company is involved in several transportation projects and mentioned that they are working with “parkhub to implement better parking solutions” and that “we have also worked with airlines to increase efficiency and scalability.”

Finally, and perhaps most importantly, as a thought leader in the software industry Gabrielsen has several intriguing views regarding the innovations the world may see on the horizon.

He mentions Quantum Computing, for instance, saying that “in the next 10 years I see Quantum computing playing a huge role in the way we use computers. Not only will this make certain computations increasingly fast, but it will also play a helping hand in curing diseases that today’s computers can’t even simulate, such as cancer. It will disrupt banking and other security forms as it can break encryption in a matter of seconds. I think that we will begin to see more and more companies invest money, talent, and time into Quantum Computing so that they can be on the forefront of that change.”

No one has a perfect understanding of the future, especially in the constantly evolving world of technology, but the views of a software engineer with Gabrielsen’s talent and experience can’t be ignored.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More